Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

Background: A biochemical recurrence (BCR) risk model was created based on pretest prostate specific antigen (PSA) and groupings by restaging prostate specific membrane antigen (PSMA) PET/CT. Methods: A cohort of 1216 BCR patients were analyzed for overall survival (OS) according to the PSA threshol...

Full description

Bibliographic Details
Main Authors: Rie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal, Irene Virgolini, Murat Tuncel, Mathieu Gauthé, Daniel S. Kapp, Finn Edler von Eyben
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
Cox regression analysis of survival
prostate specific antigen (PSA) relapse
prostate specific membrane antigen (PSMA) PET/CT
restaging
Online Access:https://www.mdpi.com/2227-9059/11/9/2333

Internet

https://www.mdpi.com/2227-9059/11/9/2333

Similar Items